Enzyme-Modified Oil Production for EPI Nutrition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a clinical need for alternative nutritional sources that do not require Pancreatic Enzyme Replacement Therapy (PERT) for individuals with Exocrine Pancreatic Insufficiency (EPI), particularly those with compromised digestive systems, and a need to reduce toxic compounds like Monochloropropandiol (MCPD) and glycidyl esters in edible oils.
Innovation Solution
A method to produce an edible enzyme-modified oil (EMO) that is substantially free of triacylglycerols (TAGs) and contaminants, with a high content of mono- and di-acylglycerols (MAGs and DAGs), using a process involving enzymatic hydrolysis and esterification to enhance the absorption of nutrients and reduce harmful compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional chemical or enzymatic hydrolysis is used to produce MAGs, then MAG content increases, but toxic compounds like MCPD and glycidyl esters are generated during the process
Solution Approach 1:
The patent changes the chemical parameters of the hydrolysis process by using specific enzymes (lipases) under controlled conditions (pH, temperature, time) to achieve complete hydrolysis of TAGs to MAGs while avoiding the formation of toxic compounds. The process uses neutral or alkaline conditions instead of acidic hydrolysis, thereby eliminating MCPD and glycidyl ester formation.
Solution Approach 2:
The patent replaces conventional chemical hydrolysis methods with enzymatic hydrolysis using lipases. This substitution of the chemical mechanism with a biological catalyst system achieves complete hydrolysis without generating harmful byproducts, as enzymes provide specific, controlled catalysis that avoids the non-specific chemical reactions responsible for toxic compound formation.
2Manufacturing precision
If conventional solvent extraction and distillation are used to fractionate MAGs, then MAG purity increases, but natural compounds like tocopherol are lost
Solution Approach 1:
The patent extracts and removes only the harmful components (MCPD, glycidyl esters, and excess FFAs) through selective precipitation and filtration processes, while leaving the beneficial natural compounds (tocopherol, phytosterols, and other oil constituents) intact in the final MAG product. This selective extraction approach maintains product purity without sacrificing nutritional value.
Solution Approach 2:
The patent changes the processing parameters by avoiding high-temperature distillation and aggressive solvent extraction. Instead, it uses controlled temperature precipitation, filtration, and controlled evaporation to separate MAGs from contaminants while preserving heat-sensitive natural compounds. The process operates at lower temperatures that protect tocopherol and other sensitive nutrients from degradation.
3Use of energy by moving object
If triacylglycerols are used in high-calorie nutritional products, then caloric density increases, but digestibility decreases for individuals with EPI
Solution Approach 1:
The patent segments the triglyceride molecule into monoacylglycerol units through complete hydrolysis of the three ester bonds. This segmentation reduces the molecular size and complexity of the fat structure, making it much easier to digest and absorb for individuals with EPI while maintaining the caloric energy content. The MAG form provides the same calories with significantly improved digestibility.
Solution Approach 2:
The patent changes the molecular structure parameter of the fat from triacylglycerol to monoacylglycerol form. This structural transformation alters the physical and chemical properties of the lipid, reducing its resistance to enzymatic breakdown and improving absorption kinetics. The MAG form maintains high caloric density while providing superior digestibility and absorption characteristics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The EMO provides a high-calorie, easily digestible nutritional source that is suitable for individuals with EPI, enhancing nutrient absorption and reducing the presence of toxic compounds, thereby addressing the nutritional needs of individuals with inefficient digestive systems while ensuring safety and efficacy.
Implementation Method 1
a lipase enzyme is added to the reaction mixture and the reaction is allowed to proceed to complete hydrolysis of the triacylglycerols to free fatty acids and monoacylglycerols
Implementation Method 2
the reaction mixture is allowed to separate into aqueous and lipid phases
Data Source
AI summary
Compositions and methods are provided for incorporating processed oils with high monoacylglyceride (MAG) content into products and food products. Methods are specifically provided for generating high MAG content processed oils.